Form 4: Sutro Biopharma Executive Linda Fitzpatrick Reports Stock Transactions
SEC Form 4 Filing
Linda Fitzpatrick, Chief People & Communications Officer at Sutro Biopharma, reports the vesting and subsequent tax withholding of shares related to restricted stock units.
Summary
- On March 5, 2025, Linda Fitzpatrick, Chief People & Communications Officer of Sutro Biopharma, engaged in transactions involving the company's common stock.
- 8,750 shares were acquired through the vesting of restricted stock units (RSUs).
- 3,594 shares were withheld by Sutro Biopharma to cover income tax obligations related to the RSU vesting at a price of $1.36.
- Following these transactions, Fitzpatrick directly owns 95,433 shares of Sutro Biopharma common stock.
- Additionally, 10,383 shares are indirectly held through the Michael A. & Linda A. Fitzpatrick Family Trust dated October 13, 1997.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing reflecting standard compensation practices; therefore, the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of compliance for corporate insiders, providing transparency into their trading activities and ownership positions in their companies.
Key Dates
| Date | Description |
|---|---|
| 10/13/1997 | Date of the Michael A. & Linda A. Fitzpatrick Family Trust |
| 03/05/2022 | Initial vesting date of RSUs (1/4th of total shares) |
| 03/05/2025 | Date of reported transactions: RSU vesting and tax withholding |
| 03/07/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.